Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups.
Yao K, Goldschmidt R, Turk M, Wesseling J, Stork-Sloots L, de Snoo F, Cristofanilli M. Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups. Breast Cancer Res Treat. 2015 Nov; 154(1):81-8.